NA
SMTI icon

NewEdge Advisors’s Sanara MedTech SMTI Stock Holding History

NewEdge Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Sell
758
-9,631
-93% -$198K ﹤0.01% 3325
2025
Q4 		$243K Buy
+10,389
New +$268K ﹤0.01% 2462
2023
Q3 		– Sell
-73
Closed -$2.93K – 3638
2023
Q2 		$2.93K Buy
+73
New +$2.99K ﹤0.01% 2979

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

NewEdge Advisors's SMTI Position: Q1 2026 in Review

NewEdge Advisors reduced its Sanara MedTech (SMTI) stake by 93% in Q1 2026, selling an estimated $198K and leaving 758 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

NewEdge Advisors first reported a position in SMTI in Q2 2023 and has held it in 3 quarters since. The position peaked at $243K in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • NewEdge Advisors held 758 shares of Sanara MedTech worth $13K as of Q1 2026.
  • NewEdge Advisors sold 9,631 Sanara MedTech shares in Q1 2026, an estimated $198K.
  • Sanara MedTech made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3325 holding.
  • NewEdge Advisors first reported a position in Sanara MedTech in Q2 2023 and has held it in 3 quarters since.
  • NewEdge Advisors's Sanara MedTech position peaked at $243K in Q4 2025.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.